Serum Testosterone:Dihydrotestosterone Ratio and CA 19‐9 in the Diagnosis of Pancreatic Cancer

The American Journal of Gastroenterology

Volumn 86, Issue 5, 1991, Pages 591-594

  Robles‐Díaz, Guillcrmo ^a   Díaz‐Sánchez, Vicente ^a   Castillo, Carlos Fernández‐del ^a   Morales, Miguel ^a   Aceves, Guillermo ^a   Galván, Elba ^a   Altamirano, Araceli ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; CA 19-9 ANTIGEN; TESTOSTERONE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY CANCER; HUMAN; MALE; PANCREAS CANCER; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BILIARY TRACT DISEASES; BILIARY TRACT NEOPLASMS; COMPARATIVE STUDY; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL NEOPLASMS; HUMAN; MALE; MIDDLE AGE; PANCREATIC DISEASES; PANCREATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; STANOLONE; TESTOSTERONE;

EID: 0026409072     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1991.tb07073.x     Document Type: Article

References (30)

1. Serum immunoreactive elastase in diagnosis of pancreatic diseases. A sensitive marker for pancreatic cancer
2. Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer
3. Galactosyltransferase isoenzyme II in the detection of pancreatic cancer: Comparison with radiologic, endoscopic, and serologic tests
4. Evaluation of a serological marker, CA 19–9 in the diagnosis of pancreatic cancer
5. Carcinoma of the pancreas. Therapeutic efficacy as defined by a sero‐diagnostic test utilizing a monoclonal antibody
6. Carcinoembryonic antigen (CEA) in the diagnosis of pancreatic cancer
7. Low serum testosterone/dihydrotestosterone ratio in patients with pancreatic carcinoma
8. Pancreolauryl test: Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function
9. Radioimmunoassay of steroids
10. Radioimmunometric assay for a monoclonal antibody‐defined tumor marker, CA 19–9
11. Utilidad diagnostica del antigeno CA 19–9 en cancer de pancreas y neoplasias de la encrucijada pancrcato‐biliar
12. The aromatisation of androstenedione by human adipose and liver tissue
13. Sex steroid enzymes aromatase and 5 α‐reductase in the pancreas: A comparison of normal adult, foetal and malignant tissue
14. 17 β‐hydroxysteroid dehydrogenase activity in canine pancreas
15. Testosterone biotransformation by the isolated perfused canine pancreas
16. Low serum testosterone concentrations in patients with carcinoma of the pancreas
17. Useful differentiation between pancreatic carcinoma and chronic pancreatitis by testosterone assay
18. Plasma levels of testosterone and hypophyseal gonadotropins in men affected by pancreatic cancer
19. Pancreatic cancer and androgen metabolism: High androstenedione and low testosterone serum levels
20. Plasma dihydrotestosterone in normal adult males and its relation to testosterone
21. Familial incomplete male pseudohermaphroditism type 2: Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias
22. Colorectal carcinoma antigens detected by hybridoma antibodies
23. Comparison of the sensitivity and specificity of the CA 19–9 and carcinoembryonic antigen assays in detecting cancer of the pancreas
24. Serum markers and clinical data in diagnosing pancreatic cancer: A contrastive approach
25. Evaluation of the utility of a radioimmunoassay for serum CA 19–9 levels in patients before and after treatment of carcinoma of the pancreas
26. Evaluation of carbohydrate antigens 19–9 and 125 in patients with pancreatic cancer
27. High sensitivity and specificity of CA 19–9 for pancreatic carcinoma in comparison to chronic pancreatitis. Serological and immunohistochemical findings
28. The evaluation of CA 19–9 antigen level in the early detection of pancreatic cancer